Avinza Side Effects

Serious Adverse Side Effects

Avinza | Morphine Sulfate Extended-Release has many serious and possibly fatal adverse side effects associated with it, such as:

• Cardiovascular side effects such as cardiac arrest, disorders of the cardiovascular system, hypotension, shock, and fainting
• Immunological side effects such as anaphylaxis, a life-threatening allergic reaction
• Musculoskeletal side effects such as muscle twitching
• Neurological side effects such as intracranial pressure
• Respiratory side effects such as shortness of breath and respiratory depression

Common Adverse Side Effects

More common and comparatively less severe adverse side effects associated with Avinza | Morphine Sulfate Extended-Release are:

• Cardiovascular side effects such as peripheral edema, or swelling of the tissues
• Dermatological side effects such as itching and sweating
• Gastrointestinal side effects such as abdominal pain, constipation, diarrhea, loss of appetite, nausea, vomiting, and dry mouth
• Hepatic side effects such as abnormal liver function
• Neurological side effects such as loss of strength, dizziness, headache, insomnia, lightheadedness, burning and prickling of the skin, and drowsiness
• Ophthalmic side effects such as lazy eye
• Psychiatric side effects such as anxiety and depression
• Renal side effects such as urinary retention
• Other side effects such as hiccup and fevers

Warnings & Recalls for Avinza

Black Box Warning

There is a “black box” warning associated with Avinza that warns patients that this drug is indicated for once daily use.  Furthermore, Avinza | Morphine Sulfate Extended-Release shouldn’t be crushed, split of chewed due to the absorption of a potentially lethal dose of morphine.  Avinza | Morphine Sulfate Extended-Release shouldn’t be used concurrently with alcohol.

Contraindications

The contraindications of Avinza | Morphine Sulfate Extended-Release are:

• Severe or acute asthma
• Compromised blood pressure
• Severe hypercarbia
• Hypersensitivity to morphine
• Paralytic ileus

Who Should Not Take This Drug

The following warnings, precautions and preexisting conditions hinder a patient’s ability to take Avinza | Morphine Sulfate Extended-Release:

• Those who are susceptible to abuse or recreational drugs
• In patients with severe renal or hepatic impairments
• Addison’s disease
• Opioid intolerant patients
• Hypothyroidism
• Prostatic hypertrophy
• Urethral stricture patients
• Elderly or debilitated patients

Avinza Treatment and Use

Avinza | Morphine Sulfate Extended-Release is a drug that is prescribed to treat moderate to severe pain.  The necessity of this drug is only for patients who require medication that is powerful enough to relieve moderate to severe pain on an extended basis.  The drug classification of Avinza | Morphine Sulfate Extended-Release is that of an opiate narcotic analgesic and works by incrementally changing the way the body reacts to pain.

The official FDA-labeled indications for this drug are for:

• Pain from heart attacks
• Use as an anesthetic
• Obstetric pain
• Moderate to severe chronic pain
• Postoperative pain
• Use as a premedication before an anesthetic procedure
• Acute pulmonary edema

Non-FDA labeled indications for this drug are:

• As an analgesic in intensive care unit
• Pain in the eye

How does Avinza work?

Morphine sulfate is known as a pure opioid agonist and in the central nervous system, promotes analgesic qualities by changing the way the brain responds to pain.  This drug also decreases gastric, biliary, and pancreatic secretion.

Dosage

Avinza | Morphine Sulfate Extended-Release is made available in the following dosages:

• 30mg
• 45mg
• 60mg
• 75mg
• 90mg
• 120mg

Other Names for Avinza

Brand Names

• Avinza


• MS Contin


• MSIR


• Kadian


• Oramorph


• Roxanol


• Kapanol

Generic Name

• Morphine Sulfate Extended-Release Capsules

Lawsuits & Legal Information for Avinza